BBWI Stock Forecast & Price Target

Bath & Body Works is supported by a compelling combination of strong brand awareness, a vertically integrated supply chain, and robust free cash flow that has improved sequentially since ’22, with ’25 up about 30%, while dividends have stayed in the mid-to-high 20’s as a percentage of FCF. The company also has multiple growth levers, including store upgrades across more than 1,900 locations, a stronger digital push through Amazon’s curated channel, and international and adjacent-category expansion such as lip, all of which could help reaccelerate demand. Although it has lost share in a mass fragrance category that was up 16% in 1Q26, its lower valuation near 7x FY2 EPS and $250M in cost savings provide downside support as innovation improves in 2H26.

Bath & Body Works is viewed negatively because its core demand remains fragile, with body care down mid-teens, home fragrance still declining, and management guiding FY26 sales down 4.5% to 2.5% versus prior-year levels despite easier comparisons ahead. The company’s revenue base is heavily exposed to stores, as 77% of fiscal 2025 sales came from more than 1,900 brick-and-mortar locations, while persistent discounting suggests the brand may be training consumers to wait for promotions rather than pay full price. Margin pressure also clouds the outlook, as FY26 gross margin is estimated at 42.4%, merchandise margin is expected to fall about 40 bps, and tariffs, inflation, and SG&A deleverage continue to offset cost savings.